Shuji Murakami

31PUBLICATIONS
71CO-AUTHORS
Liquid biopsiesMolecular targetsCancer diagnosisPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Jul 15, 2026
Comparison of Amplicon-Based Next-Generation Sequencing Testing and Immunohistochemical Staining in Detecting Anaplastic Lymphoma Kinase Fusion Genes in Non-Small-Cell Lung Cancer: A Large Single-Centre Cohort Study.

|Jun 02, 2026
Clinical Utility of Comprehensive Genomic Profiling for Advanced Non-Small Cell Lung Cancer: A Single-Center Retrospective Study.

|Jan 26, 2026
Utility of AMOY polymerase chain reaction panel in detecting non-small cell lung cancer using pleural cell block.

Shuji Murakami, Kanako Shinada, Yuka Otsuzumi

|May 23, 2025
KEYNOTE-A17: First-Line Pembrolizumab Plus Cisplatin-Pemetrexed in Japanese Participants With Advanced Pleural Mesothelioma.

Takashi Kijima, Terufumi Kato, Yasushi Goto

|Aug 29, 2024
Prognostic Significance of Plasma Neutrophil Extracellular Trap Levels in Patients with Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.

Shun Horaguchi, Yoshiro Nakahara, Yuka Igarashi

|May 03, 2024
Comparison of SP263 and 22C3 pharmDx assays to test programmed death ligand-1 (PD-L1) expression in surgically resected non-small cell lung cancer.

Naoko Shigeta, Shuji Murakami, Tomoyuki Yokose

Pageof 6

Frequent Collaborators

8 joint publications

Haruhiro Saito

3 joint publications

Hidehito Horinouchi

3 joint publications

Kanako Shinada

2 joint publications

Tetsuro Kondo